Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi

Elena Artimovich, Kristan Schneider, Terrie E. Taylor, James G. Kublin, Fraction K. Dzinjalamala, Ananias A. Escalante, Christopher V. Plowe, Miriam K. Laufer, Shannon Takala-Harrison

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: In 2007, Malawi replaced sulfadoxine-pyrimethamine (SP) with an artemisinin-based combination therapy as the first-line treatment for uncomplicated Plasmodium falciparum malaria in response to failing SP efficacy. Here we estimate the effect of reduced SP pressure on the prevalence of SP-resistant parasites and the characteristics of the associated selective sweeps flanking the resistance loci. Methods: Samples obtained from individuals with clinical malaria during a period of high SP use (1999-2001), a transitional period (2007-2008), and a period of low SP use (2012) were genotyped for resistance markers at pfdhfr-ts codons 51, 59, and 108 and pfdhps codons 437, 540, and 581. Expected heterozygosity was estimated to evaluate the genetic diversity flanking pfdhfr-ts and pfdhps. Results: An increase in the prevalence of the resistance haplotypes DHFR 51I/59R/108N and DHPS 437G/540E occurred under sustained drug pressure, with no change in haplotype prevalence 5 years after reduction in SP pressure. The DHPS 437G/540E/581G haplotype was observed in 2007 and increased in prevalence during a period of reduced SP pressure. Changes to the sweep characteristics flanking pfdhfr-ts and pfdhps were minimal. Conclusions: In contrast to the rapid and complete return of chloroquine-susceptible falciparum malaria after chloroquine was withdrawn from Malawi, a reemergence of SP efficacy is unlikely in the near future.

Original languageEnglish (US)
Pages (from-to)694-701
Number of pages8
JournalJournal of Infectious Diseases
Volume212
Issue number5
DOIs
StatePublished - 2015

Fingerprint

Malawi
Pressure
Pharmaceutical Preparations
Haplotypes
Falciparum Malaria
Chloroquine
Codon
pyrimethamine drug combination fanasil
Malaria
Parasites

Keywords

  • DHFR
  • DHPS
  • Malaria
  • Pyrosequencing
  • Resistance
  • Selective sweeps
  • Sulfadoxine-pyrimethamine

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy

Cite this

Artimovich, E., Schneider, K., Taylor, T. E., Kublin, J. G., Dzinjalamala, F. K., Escalante, A. A., ... Takala-Harrison, S. (2015). Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. Journal of Infectious Diseases, 212(5), 694-701. https://doi.org/10.1093/infdis/jiv078

Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. / Artimovich, Elena; Schneider, Kristan; Taylor, Terrie E.; Kublin, James G.; Dzinjalamala, Fraction K.; Escalante, Ananias A.; Plowe, Christopher V.; Laufer, Miriam K.; Takala-Harrison, Shannon.

In: Journal of Infectious Diseases, Vol. 212, No. 5, 2015, p. 694-701.

Research output: Contribution to journalArticle

Artimovich, E, Schneider, K, Taylor, TE, Kublin, JG, Dzinjalamala, FK, Escalante, AA, Plowe, CV, Laufer, MK & Takala-Harrison, S 2015, 'Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi', Journal of Infectious Diseases, vol. 212, no. 5, pp. 694-701. https://doi.org/10.1093/infdis/jiv078
Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante AA et al. Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. Journal of Infectious Diseases. 2015;212(5):694-701. https://doi.org/10.1093/infdis/jiv078
Artimovich, Elena ; Schneider, Kristan ; Taylor, Terrie E. ; Kublin, James G. ; Dzinjalamala, Fraction K. ; Escalante, Ananias A. ; Plowe, Christopher V. ; Laufer, Miriam K. ; Takala-Harrison, Shannon. / Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. In: Journal of Infectious Diseases. 2015 ; Vol. 212, No. 5. pp. 694-701.
@article{5bd48e57dfb64177805d4b891242c5ef,
title = "Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi",
abstract = "Background: In 2007, Malawi replaced sulfadoxine-pyrimethamine (SP) with an artemisinin-based combination therapy as the first-line treatment for uncomplicated Plasmodium falciparum malaria in response to failing SP efficacy. Here we estimate the effect of reduced SP pressure on the prevalence of SP-resistant parasites and the characteristics of the associated selective sweeps flanking the resistance loci. Methods: Samples obtained from individuals with clinical malaria during a period of high SP use (1999-2001), a transitional period (2007-2008), and a period of low SP use (2012) were genotyped for resistance markers at pfdhfr-ts codons 51, 59, and 108 and pfdhps codons 437, 540, and 581. Expected heterozygosity was estimated to evaluate the genetic diversity flanking pfdhfr-ts and pfdhps. Results: An increase in the prevalence of the resistance haplotypes DHFR 51I/59R/108N and DHPS 437G/540E occurred under sustained drug pressure, with no change in haplotype prevalence 5 years after reduction in SP pressure. The DHPS 437G/540E/581G haplotype was observed in 2007 and increased in prevalence during a period of reduced SP pressure. Changes to the sweep characteristics flanking pfdhfr-ts and pfdhps were minimal. Conclusions: In contrast to the rapid and complete return of chloroquine-susceptible falciparum malaria after chloroquine was withdrawn from Malawi, a reemergence of SP efficacy is unlikely in the near future.",
keywords = "DHFR, DHPS, Malaria, Pyrosequencing, Resistance, Selective sweeps, Sulfadoxine-pyrimethamine",
author = "Elena Artimovich and Kristan Schneider and Taylor, {Terrie E.} and Kublin, {James G.} and Dzinjalamala, {Fraction K.} and Escalante, {Ananias A.} and Plowe, {Christopher V.} and Laufer, {Miriam K.} and Shannon Takala-Harrison",
year = "2015",
doi = "10.1093/infdis/jiv078",
language = "English (US)",
volume = "212",
pages = "694--701",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi

AU - Artimovich, Elena

AU - Schneider, Kristan

AU - Taylor, Terrie E.

AU - Kublin, James G.

AU - Dzinjalamala, Fraction K.

AU - Escalante, Ananias A.

AU - Plowe, Christopher V.

AU - Laufer, Miriam K.

AU - Takala-Harrison, Shannon

PY - 2015

Y1 - 2015

N2 - Background: In 2007, Malawi replaced sulfadoxine-pyrimethamine (SP) with an artemisinin-based combination therapy as the first-line treatment for uncomplicated Plasmodium falciparum malaria in response to failing SP efficacy. Here we estimate the effect of reduced SP pressure on the prevalence of SP-resistant parasites and the characteristics of the associated selective sweeps flanking the resistance loci. Methods: Samples obtained from individuals with clinical malaria during a period of high SP use (1999-2001), a transitional period (2007-2008), and a period of low SP use (2012) were genotyped for resistance markers at pfdhfr-ts codons 51, 59, and 108 and pfdhps codons 437, 540, and 581. Expected heterozygosity was estimated to evaluate the genetic diversity flanking pfdhfr-ts and pfdhps. Results: An increase in the prevalence of the resistance haplotypes DHFR 51I/59R/108N and DHPS 437G/540E occurred under sustained drug pressure, with no change in haplotype prevalence 5 years after reduction in SP pressure. The DHPS 437G/540E/581G haplotype was observed in 2007 and increased in prevalence during a period of reduced SP pressure. Changes to the sweep characteristics flanking pfdhfr-ts and pfdhps were minimal. Conclusions: In contrast to the rapid and complete return of chloroquine-susceptible falciparum malaria after chloroquine was withdrawn from Malawi, a reemergence of SP efficacy is unlikely in the near future.

AB - Background: In 2007, Malawi replaced sulfadoxine-pyrimethamine (SP) with an artemisinin-based combination therapy as the first-line treatment for uncomplicated Plasmodium falciparum malaria in response to failing SP efficacy. Here we estimate the effect of reduced SP pressure on the prevalence of SP-resistant parasites and the characteristics of the associated selective sweeps flanking the resistance loci. Methods: Samples obtained from individuals with clinical malaria during a period of high SP use (1999-2001), a transitional period (2007-2008), and a period of low SP use (2012) were genotyped for resistance markers at pfdhfr-ts codons 51, 59, and 108 and pfdhps codons 437, 540, and 581. Expected heterozygosity was estimated to evaluate the genetic diversity flanking pfdhfr-ts and pfdhps. Results: An increase in the prevalence of the resistance haplotypes DHFR 51I/59R/108N and DHPS 437G/540E occurred under sustained drug pressure, with no change in haplotype prevalence 5 years after reduction in SP pressure. The DHPS 437G/540E/581G haplotype was observed in 2007 and increased in prevalence during a period of reduced SP pressure. Changes to the sweep characteristics flanking pfdhfr-ts and pfdhps were minimal. Conclusions: In contrast to the rapid and complete return of chloroquine-susceptible falciparum malaria after chloroquine was withdrawn from Malawi, a reemergence of SP efficacy is unlikely in the near future.

KW - DHFR

KW - DHPS

KW - Malaria

KW - Pyrosequencing

KW - Resistance

KW - Selective sweeps

KW - Sulfadoxine-pyrimethamine

UR - http://www.scopus.com/inward/record.url?scp=84927790743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927790743&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiv078

DO - 10.1093/infdis/jiv078

M3 - Article

VL - 212

SP - 694

EP - 701

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -